Therapeutics
Developing Next Generation Therapeutics for Healthy Life
Batoclimab HBM9161(HanAll)
FcRn
MG*
NMOSD*
TED*
ITP*
CIDP*
PV*
Greater
China
Greater
China
Greater
China
Greater
China
Greater
China
Greater
China
Tanfanercept HBM9036(Hanall)
TNFα
Dry Eye Disease
Greater
China
HBM9378
TSLP
Asthma
Global
HBM9022(AbbVie; Utrecht University; Erasmus MC)
SARS-COV-2
COVID-19
Global License to AbbVie
HBM4003
CTLA-4
Advanced Solid Tumors
Advanced Melanoma & Other Solid Tumors
Advanced NSCLC & Other Solid Tumors
Global
Global
Global
HBM7022
Claudin18.2xCD3
Solid Tumors
Global License to AstraZeneca
HBM1007
CD73
Solid Tumors
Global
HBM7020
BCMAxCD3
Multiple Myeloma
Ex-Greater China
HBM7008
B7H4x4-1BB
Solid Tumors
Global
HBM1022
CCR8
Solid Tumors
Global
HBM1020
B7H7
Solid Tumors
Global
HBM
Partner
Registrational Clinical Trial
Monotherapy
PD1 / Chemo
Greater China rights out-licensed to Hualan Genetics
* MG = Myasthenia Gravis
* NMOSD = Neuromyelitis Optica Spectrum Disorder
* ITP = Immune Thrombocytopenic Purpura
* TED = Thyroid Eye Disease
* CIDP = Chronic Inflammatory Demyelinating Polyradiculoneuropathy
* PV = Pemphigus Vulgaris
* HCC = Hepatocellular Carcinoma
* NEN = Neuroendocrine Neoplasms
* NSCLC = Non-Small Cell Lung Cancer